Author: Andrew Celentano - Page 5 - Start Medical Product Development

Vincora Receives FDA Approval to Initiate U.S. Early Feasibility Study of Transcatheter Chordal Repair System

October 27, 2026

MAPLE GROVE, Minn., Oct. 27, 2026 /PRNewswire/ — Vincora (NeoChord, Inc. d/b/a Vincora), a medical technology company developing transcatheter therapies for mitral valve repair, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Investigational Device Exemption (IDE) to initiate a U.S. Early Feasibility Study (EFS) of its investigational Transcatheter Chordal Repair System for the treatment of degenerative mitral valve regurgitation.

Glioblastoma’s secret weapon: Silencing the brain’s off switch

October 27, 2026

Researchers at Baylor College of Medicine have discovered a new strategy that glioblastoma, the most common and aggressive form of adult brain cancer, uses to fuel its own growth. Published in the journal Neuron, the study shows in animal models that glioblastoma hijacks the activity of neighboring brain cells, flipping them from a role that limits tumor growth to one that promotes it. The findings point to new treatment possibilities for this deadly cancer, which has seen only minimal gains in patient survival over the past half century.

Wearable EEG patch records stable brain signals over 24 hours, including sleep

October 27, 2026

Reliably recording brain activity over many hours has so far been fraught with technical and practical challenges. While traditional electroencephalography (EEG) systems provide meaningful data, they are often uncomfortable and typically limited to controlled testing environments. Is it even possible to record EEG signals with good signal quality in everyday situations?

Sensonics launches human feasibility study for transmitter-free Eversense CGM

October 26, 2026

Senseonics (NYSE: SENS) has launched its first clinical study of a transmitter-free version of its Eversense 365 continuous glucose monitor.

Implantable device uses ultrasound to improve drug delivery to the brain

October 26, 2026

This targeted approach could offer a way to prevent the recurrence of aggressive brain tumors.

FDA clears Coreline Soft’s AVIEW Aorta Metrics software

October 26, 2026

The regulatory clearance brings Coreline Soft’s total to 13 FDA 510(k) clearances and broadens its chest AI portfolio.

RunStar introduces new wireless blood pressure monitor

October 26, 2026

The LoopGo integrates the monitoring unit directly into an adjustable arm cuff, eliminating external tubes and cabling.

Elucid cardio imaging tech wins FDA clearance

October 26, 2026

Elucid recently received FDA clearance for its AI-powered FFR-IQ software, which provides a noninvasive estimate of fractional flow reserve from coronary CT angiography.

Wireless neural chip tracks brain changes in real time after Alzheimer’s drug administration

October 26, 2026

A joint research team led by KAIST has used a small, implantable neural chip to wirelessly monitor real-time changes in a neurotransmitter involved in memory and learning after an Alzheimer’s drug has been administered.

Ultrasonic technology enables earlier stress-fracture detection

October 24, 2026

Tibial stress fractures are among the most common overuse injuries affecting military personnel, but they can be difficult to identify in their earliest stages. Small stresses in the bone may develop before an injury becomes apparent through conventional diagnostic tools, creating a window of opportunity for earlier detection to enable intervention.